You are viewing the site in preview mode
Skip to main content
| Parameter | Cohort (n = 111) |
|---|
| Median age | 68 (42–90) years |
| Male | 77 (69.4%) |
| ECOG PS |
| 0 | 13 (11.7%) |
| 1 | 70 (63.1%) |
| 2 | 26 (23.4%) |
| 3 | 2 (1.8%) |
| Stage |
| IIIA | 60 (54.1%) |
| IIIB | 51 (45.9%) |
| Histology |
| Adenocarcinoma | 52 (46.8%) |
| Squamous Cell Carcinoma | 44 (39.6%) |
| Large Cell | 3 (2.7%) |
| Adenosquamous | 2 (1.8%) |
| NOS | 10 (9.0%) |
| Median RT dose | 66 (60–74) Gy |
| 60–66 Gy | 84 (75.7%) |
| > 66–74 Gy | 27 (24.3%) |
| Concurrent chemotherapy | 106 (95.5%) |
| Median follow up, months | 38.7 (0.1–109.2) |
- Abbreviations: ECOG PS performance score, NOS not otherwise specified
- * Continuous variables are shown with range and categorical variables with percentages in parenthesis
